In whose interest? Relationships between health consumer groups and the pharmaceutical industry in the UK

Sociology of Health and Illness

Volumn 30, Issue 6, 2008, Pages 929-943

  Jones, Kathryn ^a  

^a DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

Disclosure; Health consumer groups; Pharmaceutical industry; Policy process; Transparency

Indexed keywords

ARTICLE; CONSUMER ADVOCACY; DRUG INDUSTRY; ETHICS; HEALTH CARE POLICY; INTERNET; INTERPERSONAL COMMUNICATION; MANAGEMENT; POLICY; PUBLIC RELATIONS; UNITED KINGDOM;

CONSUMER ADVOCACY; DISCLOSURE; DRUG INDUSTRY; ETHICS; GREAT BRITAIN; HEALTH POLICY; INTERINSTITUTIONAL RELATIONS; INTERNET; ORGANIZATIONAL POLICY; POLICY MAKING;

EID: 50849121404     PISSN: 01419889     EISSN: 14679566     Source Type: Journal    
DOI: 10.1111/j.1467-9566.2008.01109.x     Document Type: Article

References (33)

1. ABPI (2005) Code of Practice for the Pharmaceutical Industry. London : Association of British Pharmaceutical Industry.
2. Allsop, J., Jones, K. Baggott, R. (2004) Health consumer groups in the UK: a new social movement? Sociology of Health and Illness, 26, 6, 737 56.
3. Alzheimer's Society (2006) Relationship with pharmaceutical companies, (www) http://www.alzheimers.org.uk (Accessed May 2007).
4. Arthritis Care (2005) Arthritis Care corporate sponsorship policy (available at http://www.arthritiscare.org.uk, accessed May 2007).
5. Arthritis Care (2006) Arthritis Care statement on Vioxx, (www) http://www.arthritiscare.org.uk (Accessed May 2007).
6. Ball, D., Tisocki, K. Herxheimer, A. (2006) Advertising and disclosure of funding on patient organisation websites, BMC Public Health, 6, 201.
7. Baggott, R. (2007) Understanding Health Policy. Bristol : Policy Press.
8. Baggott, R. Forster, R. (2008) Health consumer and patients' organizations in Europe, Health Expectations, 11, 1, 85 94.
9. Baggott, R., Allsop, J. Jones, K. (2005) Speaking for Patients and Carers. Basingstoke : Palgrave.
10. BMJ (2007) Should patient groups accept money from drug companies? (www) http://resources.bmj.com/bmj/interactive/polls/accept-money-poll (Accessed May 2007).
11. Busfield, J. (2006) Pills, power, people: sociological understandings of the pharmaceutical industry, Sociology, 40, 297 314.
12. Cancerbackup (2006) Cancerbackup policy and guidelines on working with pharmaceutical companies (available at http://www.cancerbackup.org.uk, accessed May 2007).
13. Department of Health (2005) Government Response to the Health Committee's Report on the Influence of the Pharmaceutical Industry (Cm 6655). London : DH.
14. Doran, E., Kerridge, I., McNeill, P. Henry, D. (2006) Empirical uncertainty and moral contest: a qualitative analysis of the relationship between medical specialists and the pharmaceutical industry in Australia, Social Science and Medicine, 62, 1510 19.
15. Duckenfield, M. Rangnekar, D 2004) Patient Groups and the Drug Development Process. London : UCL.
16. Fox, N. Ward, K. (2005) Globalised consumption and the challenge to pharmaceutical governance, British Medical Journal, 331, 40 2.
17. Frith, M. (2005) Exposed: Vioxx firm's cash payments made to arthritis charities, The Independent, 24 August.
18. Gray, R., Owen, D. Adams, C. (1996) Accounting and Accountability: Changes and Challenges in Corporate Social and Environmental Reporting. London : Prentice-Hall.
19. Health Action International (2002) Patients' Groups and Industry Funding. Netherlands : HAI.
20. Health Coalition Initiative (2005) A Framework Document for Developing Partnerships between VHOs and the Pharmaceutical Industry. London : HCI.
21. Health Committee (2005) The Influence of the Pharmaceutical Industry, HC 42-I. London : TSO.
22. HONF (2007) HonCode accreditation system, (available at http://www.hon.ch, accessed May 2007).
23. Hurst, S.A. Mauron A. (2008) A question of method: the ethics of managing conflicts of interest, EMBO Reports, 9, 2, 119 23.
24. Jack, A. (2006) Too close for comfort? British Medical Journal, 333, 13.
25. nd Edition. London : Ashgate.
26. Lofgren, H. (2004) Pharmaceuticals and the consumer movement: the ambivalences of 'patient power', Australian Health Review, 28, 2, 228 37.
27. Moon, C. Bonny, C. (eds) (2001) Business Ethics. London : Economist Books.
28. Moran, M. (1999) Governing the Healthcare State. Manchester : MUP.
29. National Heart Forum (2006) Supporting the NHF (available at http://www.heartforum.org.uk, accessed May 2007).
30. O'Donovan, O. (2007) Corporate colonization of health activism? Irish health advocacy organizations' modes of engagement with pharmaceutical corporations, International Journal of Health Services, 4, 37, 711 33.
31. Salter, B. (2004) The New Politics of Medicine. Basingstoke : Palgrave.
32. Which? (2003) Who's injecting the cash?, Which? April 24 5.
33. Wilson, J. (1998) Working with the Pharmaceutical Industry. London : LMCA.